BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9524540)

  • 1. [Acetylsalicylic acid in ischemic insult].
    Noth J
    Dtsch Med Wochenschr; 1998 Feb; 123(9):270. PubMed ID: 9524540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary prevention of cerebral ischemia. AMEVASC. Mexican Association of Cerebrovascular Disease].
    Barinagarrementeria F; Amaya L; Guzmán JL; Ibarra O; Loy Mdel C; Millán R; Neri G; Villarreal J; Araúz A; Cantú C
    Rev Invest Clin; 2002; 54(3):257-61. PubMed ID: 12183895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis].
    Zarranz Imirizaldu JJ
    Med Clin (Barc); 1997 Dec; 109(20):802-7. PubMed ID: 9493161
    [No Abstract]   [Full Text] [Related]  

  • 5. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin, aspirin, or both after myocardial infarction.
    Amit G; Ilia R; Zahger D
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
    Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
    J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 12. [ASS plus clopidogrel in contraindication for marcumar].
    Einecke D
    MMW Fortschr Med; 2009 Apr; 151(16):10-1. PubMed ID: 19658286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet inhibition remains the second choice. "Anticoagulation should always be the goal" (interview by Dr. med. Jochen Aumiller)].
    Connolly S
    MMW Fortschr Med; 2009 Apr; 151(16):11. PubMed ID: 19658287
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy after myocardial infarction.
    Becker RC
    N Engl J Med; 2002 Sep; 347(13):1019-22. PubMed ID: 12324559
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulants and antiplatelet agents in acute ischemic stroke.
    Pellegrino TR
    Va Med Q; 1998; 125(2):125-7. PubMed ID: 9577715
    [No Abstract]   [Full Text] [Related]  

  • 16. CURE--clopidogrel's major advance.
    Jackson G
    Int J Clin Pract; 2001 Apr; 55(3):155. PubMed ID: 11351766
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral anticoagulation in activated protein C resistance?].
    Stiegler H
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1619. PubMed ID: 9011491
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.